SEC Tracker
Get the app

ARS Pharmaceuticals SPRY

ARS Pharmaceuticals, Inc. announced in its corporate presentation

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when ARS Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Mannkind MNKD public float $1.1B, Jun 30, 2025
  2. Harrow HROW public float $1.0B, Jun 30, 2025
  3. Innoviva INVA public float $1.3B, Jun 30, 2025
  4. Collegium Pharmaceutical COLL public float $926M, Jun 30, 2025
  5. CorMedix CRMD public float $910M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.